McKesson Corporation MCK
1,084.43 USD -7.24 (-0.66%)
Regular-session close
1,084.43 0.00 0.00%
After hours · Nov 18, 5:20 PM ET
1,073.12 Day range 1,091.08
723.68 52-week range 1,121.50
- YTD
- +32.20%
- 1 year
- +25.99%
News
benzinga.com Barclays Maintains Overweight on McKesson, Raises Price Target to $1235 Barclays analyst Glen Santangelo maintains McKesson (NYSE:MCK) with a Overweight and raises the price target from $1000 to $1235.
defenseworld.net Head to Head Contrast: INVO Fertility (NASDAQ:IVF) vs. McKesson (NYSE:MCK) McKesson (NYSE: MCK - Get Free Report) and INVO Fertility (NASDAQ: IVF - Get Free Report) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the…
benzinga.com Here's How Much $1000 Invested In McKesson 15 Years Ago Would Be Worth Today McKesson (NYSE:MCK) has outperformed the market over the past 15 years by 6.37% on an annualized basis producing an average annual return of 19.38%. Currently, McKesson has a market capitalization of…
defenseworld.net McKesson Corporation $MCK Stock: Allworth Financial LP Increases Holdings Allworth Financial LP grew its position in McKesson Corporation (NYSE: MCK) by 15.7% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange…
seekingalpha.com McKesson: Slower FY2028 Revenue Growth Makes Today's Premium Less Attractive McKesson Corporation maintains a 'Hold' rating as shares trade at a premium, with limited upside to a $1,115 target price. Strong demand for specialty drugs and services drives growth, but GLP-1…
zacks.com Here is What to Know Beyond Why McKesson Corporation (MCK) is a Trending Stock Recently, Zacks.com users have been paying close attention to McKesson (MCK). This makes it worthwhile to examine what the stock has in store.
fxempire.com Sales of Pharmaceuticals, GLP-1s Send McKesson Shares to New Highs McKesson Corporation (MCK) shares up over 235% since May 2022 thanks to institutional support.benzinga.com JP Morgan Maintains Overweight on McKesson, Raises Price Target to $1255 JP Morgan analyst Lisa Gill maintains McKesson (NYSE:MCK) with a Overweight and raises the price target from $1042 to $1255.
benzinga.com UBS Maintains Buy on McKesson, Raises Price Target to $1250 UBS analyst Kevin Caliendo maintains McKesson (NYSE:MCK) with a Buy and raises the price target from $1200 to $1250.
benzinga.com TD Cowen Maintains Buy on McKesson, Raises Price Target to $1200 TD Cowen analyst Charles Rhyee maintains McKesson (NYSE:MCK) with a Buy and raises the price target from $1006 to $1200.
benzinga.com Leerink Partners Maintains Outperform on McKesson, Raises Price Target to $1200 Leerink Partners analyst Michael Cherny maintains McKesson (NYSE:MCK) with a Outperform and raises the price target from $1070 to $1200.
benzinga.com RBC Capital Maintains Sector Perform on McKesson, Raises Price Target to $965 RBC Capital analyst Ryan Halsted maintains McKesson (NYSE:MCK) with a Sector Perform and raises the price target from $845 to $965.
benzinga.com Evercore ISI Group Maintains Outperform on McKesson, Raises Price Target to $1200 Evercore ISI Group analyst Elizabeth Anderson maintains McKesson (NYSE:MCK) with a Outperform and raises the price target from $1000 to $1200.
benzinga.com UPDATE: McKesson Raises FY2027 Adj EPS Guidance from $44.20-$45.00 to $45.60-$46.40 vs $44.71 Est; Raises FY2027 Sales Guidance from $423.601B-$439.739B to $427.636B-$443.773B vs $432.063B Est McKesson (NYSE:MCK) raises FY2027 Adj EPS guidance from $44.20-$45.00 to $45.60-$46.40 vs $44.71 analyst estimate. Raises FY2027 sales outlook from $423.601 billion-$439.739 billion to $427.636…
benzinga.com McKesson Q2 2027 Earnings Call Transcript McKesson (NYSE:MCK) reported second-quarter financial results on Wednesday. The transcript from the company’s second-quarter earnings call has been provided below.This transcript is brought to you by…benzinga.com McKesson Q2 Adj. EPS $11.68 Beats $10.70 Estimate, Sales $110.957B Beat $109.875B Estimate McKesson (NYSE:MCK) reported quarterly earnings of $11.68 per share which beat the analyst consensus estimate of $10.70 by 9.16 percent. This is a 18.46 percent increase over earnings of $9.86 per…
benzinga.com Dow Rallies 2.9%, Oil Sinks 7% After Midterms: Stock Market Today Democrats' sweep of Congress lifted hyperscalers and retailers, sank oil and data-center builders, and pulled yields lower.
benzinga.com ARM, McDonald's On Deck Wednesday As AI Demand, Consumer Spending Face Test ARM Holdings headlines Wednesday’s reports, with investors looking for evidence that AI-related demand can support the chip designer after a sharp stock pullback. McDonald’s, Novo Nordisk, Uber…
benzinga.com Here's How Much $100 Invested In McKesson 5 Years Ago Would Be Worth Today McKesson (NYSE:MCK) has outperformed the market over the past 5 years by 25.96% on an annualized basis producing an average annual return of 36.71%. Currently, McKesson has a market capitalization of…benzinga.com Mizuho Maintains Neutral on McKesson, Raises Price Target to $1020 Mizuho analyst Steven Valiquette maintains McKesson (NYSE:MCK) with a Neutral and raises the price target from $905 to $1020.
finance.yahoo.com Quantinuum Inc. (QNT) Latest Stock News & Headlines - Yahoo Finance Quantinuum reported strong bookings and revenue growth, but remains deeply unprofitable and cash-flow negative. Its Japan expansion with RIKEN and SoftBank adds commercial potential, while valuation…
finance.yahoo.com Cerebras Systems Inc. (CBRS) Cerebras reported strong third-quarter growth, raised 2026 guidance to $940 million–$960 million, and announced a Microsoft compute agreement. The central issue remains execution: data-center delays…
finance.yahoo.com Infleqtion, Inc. (INFQ) Latest Stock News & Headlines - Yahoo Finance As of 12:02:52 PM EST. Market Open. INFQ Q3 2026 earnings call Replay the call for the latest insights.
finance.yahoo.com Swarmer, Inc (SWMR) This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. Swarmer completed its ...
247wallst.com Mckesson Corporation Looking ahead to 2030, our model projects MCK could trade at an average price of $1,645.07, with a potential range between $1,233.80 and $2,056.33. This represents a potential 50.3% return from ...
finance.sina.com.cn 麦克森收跌1.21%,成交额7.81亿美元 11月18日,麦克森(MCK)收跌1.21%,报1091.67美元,成交额7.81亿美元,市值1260.41亿美元。 公司最新财报显示,季度营收1109.57亿美元,同比增长7.57%;净利润12.18亿美元,同比增长9.73%。 公司简介…
finance.sina.com.cn 麦克森收跌0.66%,成交额7.25亿美元 11月19日,麦克森(MCK)收跌0.66%,报1084.43美元,成交额7.25亿美元,市值1252.05亿美元。 公司最新财报显示,季度营收1109.57亿美元,同比增长7.57%;净利润12.18亿美元,同比增长9.73%。 公司简介…
finance.yahoo.com The Open Question In McKesson's Two New Deals McKesson (MCK) is spending to grow further beyond drug distribution into clinical research and home infusion. The company ...
quiverquant.com New Analyst Forecast: $MCK Given $1235 Price Target Multiple analysts have issued price targets for $MCK recently. We have seen 10 analysts offer price targets for $MCK in the ...
247wallst.com Clover Health (CLOV) Stock Falls 8.6% Today An 8.6% slide to $4.31 came alongside declines across managed care: Humana fell 8.46%, Elevance 6.27% and CVS 3.19% in the ...
finance.yahoo.com The Early Signs Before McKesson Stock's 44% Rise McKesson (MCK) stock returned 43.6% from May 19 to November 17, 2026, against 0.37% for the S&P 500. Over that window, ...
247wallst.com UnitedHealth Group Drops 10.7% With No Clear Catalyst A 10.7% intraday drop to $344.98 hit the largest managed-care name, and rival CVS Health fell 4.61% in the same session. No catalyst is established in the available evidence.
investors.com IBD Live Q&A, Two Key Stock Lists And Transcript For Nov. 17, 2026 Welcome to IBD Live! This list of FAQs and useful links will speed your learning curve. Some users have reported the inability to access the IBD Live show page on... Read More ...
insidermonkey.com Morgan Stanley’s Vintage Values 2027: 10 Stocks Analysts See Climbing Further According to a3 Bloomberg report, strategists at a major Wall Street bank expect the S&P 500 to reach 8,700 within 12 months.
ad-hoc-news.de McKesson-Aktie: Barclays hebt Kursziel auf 1.235 US-Dollar Barclays hat am Mittwoch, 18. November 2026, das Kursziel für McKesson von 1.000 auf 1.235 US-Dollar angehoben und die ...
fool.com Eli Lilly vs. Novo Nordisk: Which GLP-1 Stock Is a Better Buy for 2027? Lilly's revenue growth is turbocharged by its weight-loss pipeline, while Novo's global footprint and far lower valuation ...
marketwatch.com McKesson Corp. stock underperforms Tuesday when compared to competitors The stock's fall snapped a two-day winning streak. Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the ...
msn.com McKesson stock is a triple threat at new all-time highs. How to trade it here. McKesson (MCK) combines robust momentum, solid profitability, and positive earnings revisions, but its valuation is pricey ...
theglobeandmail.com Eli Lilly vs. Novo Nordisk: Which GLP-1 Stock Is a Better Buy for 2027? The global demand for next-generation metabolic treatments has sparked a fierce competition, forcing retail investors to decide between Eli Lilly & Co. (NYSE:LLY) and Novo Nordisk ...
